Invizius
company
About
Invizius is developing treatments to help hemodialysis patients live longer, feel better, and suffer fewer cardiovascular complications.
- 1 - 10
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- £5.30M
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Jan 1, 2018
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
£8.55M
Invizius has raised a total of
£8.55M
in funding over 2 rounds. Their latest funding was raised on
May 6, 2021 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 6, 2021 | Series A | £5.30M | 1 |
Mercia Fund Managers
|
— | Detail |
| Sep 11, 2019 | Series A | £2.75M | 1 |
Mercia Fund Managers
|
— | Detail |
| May 2, 2018 | Seed | £500K | 1 |
Mercia Fund Managers
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
3
1
Invizius is funded by 1 investors.
Mercia Fund Managers
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Mercia Fund Managers
|
Yes | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
